ID
13247
Description
AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS); ODM derived from: https://clinicaltrials.gov/show/NCT00071006
Link
https://clinicaltrials.gov/show/NCT00071006
Keywords
Versions (1)
- 1/26/16 1/26/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
January 26, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Myeloid Leukemia (AML) NCT00071006
Eligibility Acute Myeloid Leukemia (AML) NCT00071006
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
candidate for chemotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0392920
Description
APL
Data type
boolean
Alias
- UMLS CUI [1]
- C0023487
Description
conditions that might confound the evaluation of safety or efficacy or increase patient risk.
Data type
boolean
Alias
- UMLS CUI [1,1]
- C2348563
- UMLS CUI [1,2]
- C0439801
- UMLS CUI [1,3]
- C0009488
Similar models
Eligibility Acute Myeloid Leukemia (AML) NCT00071006
- StudyEvent: Eligibility
C3463824 (UMLS CUI [2])
C0232804 (UMLS CUI [2])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])